Literature DB >> 16629174

Vesicular transport of fe and interaction with other metal ions in polarized Caco2 cell monolayers.

Maria C Linder1, Mizue Moriya, Anne Whon, Azeb Kassa, Cynthia Gilley.   

Abstract

Two aspects of the mechanisms by which iron is absorbed by the intestine were studied in the Caco2 cell model, using 59Fe(II)-ascorbate. Data showing the importance of vesicular processes and cycling of apotransferrin (apoTf) to uptake and overall transport of Caco2 cell monolayers (or basolateral 59Fe release) were obtained by comparing effects of: a) adding apoTf to the basal chamber; b) adding vesicular transport inhibitors; or c) cooling to 4 degrees C. These showed that apoTf may be involved in as much as half of Fe transfer across the basolateral membrane, and that vesicular processes may also play a role in non-apoTf-dependent Fe transport. Studies were initiated to examine potential interactions of other metal ions with Fe(II) via DMT1. Kinetic data showed a single, saturable process for uptake of Fe(II) that was pH dependent and had a Km of 7 microM. An excess of Mn(II) and Cu(I) over Fe(II) of 200: 1 (microM: microM) in 1 mM ascorbate markedly inhibited Fe uptake. The kinetics were not competitive. Km increased and Vmax decreased. We conclude that vesicular transport, involving endo- and exocytosis at both ends of the enterocyte, is a fundamental aspect of intestinal iron absorption and that DMT1 may function as a transporter not just for divalent but also for monovalent metal ions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629174     DOI: 10.4067/s0716-97602006000100016

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  9 in total

1.  Prion protein promotes kidney iron uptake via its ferrireductase activity.

Authors:  Swati Haldar; Ajai Tripathi; Juan Qian; Amber Beserra; Srinivas Suda; Matthew McElwee; Jerrold Turner; Ulrich Hopfer; Neena Singh
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

2.  Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism.

Authors:  Mizue Moriya; Yi-Hsuan Ho; Anne Grana; Linh Nguyen; Arrissa Alvarez; Rita Jamil; M Leigh Ackland; Agnes Michalczyk; Pia Hamer; Danny Ramos; Stephen Kim; Julian F B Mercer; Maria C Linder
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-25       Impact factor: 4.249

Review 3.  Molecular mechanisms involved in intestinal iron absorption.

Authors:  Paul Sharp; Surjit-Kaila Srai
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 4.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

5.  Mathematical Modeling of Intestinal Iron Absorption Using Genetic Programming.

Authors:  Andrea Colins; Ziomara P Gerdtzen; Marco T Nuñez; J Cristian Salgado
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

6.  Mathematical modeling of the relocation of the divalent metal transporter DMT1 in the intestinal iron absorption process.

Authors:  Layimar Cegarra; Andrea Colins; Ziomara P Gerdtzen; Marco T Nuñez; J Cristian Salgado
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

7.  Secretion and uptake of copper via a small copper carrier in blood fluid.

Authors:  B D Gioilli; T Z Kidane; H Fieten; M Tellez; M Dalphin; A Nguyen; K Nguyen; M C Linder
Journal:  Metallomics       Date:  2022-03-25       Impact factor: 4.526

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

Review 9.  Labile iron in cells and body fluids: physiology, pathology, and pharmacology.

Authors:  Zvi Ioav Cabantchik
Journal:  Front Pharmacol       Date:  2014-03-13       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.